Eduardo Forleo-Neto

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, Richard Keen, Philippe Orcel, Thomas Funck-Brentano, Christian Roux, Sami Kolta, Annalisa Madeo, Judith S Bubbear, Jacek Tabarkiewicz, Małgorzata Szczepanek, Javier Bachiller-Corral, Angela M Cheung, Kathryn M Dahir, Esmée Botman, Pieter G Raijmakers, Mona Al Mukaddam, Lianne Tile, Cynthia Portal-Celhay, Neena Sarkar, Peijie Hou, Bret J Musser, Anita Boyapati, Kusha A Mohammadi, Scott J Mellis, Andrew J Rankin, Aris N Economides, Dinko Gonzalez Trotter, Gary A Herman, Sarah J O'Meara, Richard DelGizzi, David M Weinreich, George D Yancopoulos, Elisabeth M W Eekhoff, Frederick S Kaplan
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial. Nature medicine (2023)
Dean A Follmann, Meagan P O'Brien, Jonathan Fintzi, Michael P Fay, David Montefiori, Allyson Mateja, Gary A Herman, Andrea T Hooper, Kenneth C Turner, Kuo- Chen Chan, Eduardo Forleo-Neto, Flonza Isa, Lindsey R Baden, Hana M El Sahly, Holly Janes, Nicole A Doria-Rose, Jacqueline Miller, Honghong Zhou, Weiping Dang, David C Benkeser, Youyi Fong, Peter B Gilbert, Mary Marovich, Myron S Cohen
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration. Nature communications 14 (1) (2023)

Eduardo Forleo-Neto.css-eqlu8i{font-size:small;padding-left:4px;}